RESULTS: At 4weekspostpartumandprior to the initiationofmoodstabilisertherapy, 19% of women with postpartum psychosishadAITD compared with only 5% in the control group.
Further tests showed that DISC1 acts like lithium, a drug commonly prescribed as moodstabiliser to patients with mental illness, inhibiting the action of a key chemical in the brain.